Lupron Depot-PED leuprolide acetate regulatory update

FDA approved an sNDA for 11.25 and 30 mg of a 3-month formulation of Lupron Depot-PED leuprolide acetate to treat central precocious puberty in children. Abbott already markets 7.5, 11.25 and 15 mg do...